Found: 16
Select item for more details and to access through your institution.
Baseline <sup>18</sup>F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lenalidomide maintenance fails to overcome the unfavourable prognosis of low NK‐cell counts in rituximab–chemotherapy responsive elderly DLBCL patients: A LYSA group study.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. 256, doi. 10.1111/bjh.18642
- By:
- Publication type:
- Article
Lenalidomide maintenance for diffuse large B‐cell lymphoma patients responding to R‐CHOP: quality of life, dosing, and safety results from the randomised controlled REMARC study.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 1, p. 84, doi. 10.1111/bjh.16300
- By:
- Publication type:
- Article
Bendamustine and rituximab in elderly patients with low‐tumour burden follicular lymphoma. Results of the LYSA phase II BRIEF study.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 1, p. 76, doi. 10.1111/bjh.15513
- By:
- Publication type:
- Article
Correction to: Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B‑cell lymphoma: results of a multicentric prospective cohort study.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 1, p. 369, doi. 10.1007/s00277-023-05497-8
- By:
- Publication type:
- Article
Prognostic relevance of sarcopenia, geriatric, and nutritional assessments in older patients with diffuse large B-cell lymphoma: results of a multicentric prospective cohort study.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 7, p. 1811, doi. 10.1007/s00277-023-05200-x
- By:
- Publication type:
- Article
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1761, doi. 10.3390/cancers14071761
- By:
- Publication type:
- Article
Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
- Published in:
- Cancer (0008543X), 1996, v. 77, n. 11, p. 2302, doi. 10.1002/(SICI)1097-0142(19960601)77:11<2302::AID-CNCR18>3.0.CO;2-0
- By:
- Publication type:
- Article
High Grade Primary Breast Lymphoma: is it a Different Clinical Entity?
- Published in:
- Breast Cancer Research & Treatment, 2005, v. 93, n. 3, p. 191, doi. 10.1007/s10549-005-5088-8
- By:
- Publication type:
- Article
Interim Update from a Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor, in Patients with Relapsed or Refractory (R/R) Follicular Lymphoma (FL).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S278, doi. 10.1016/j.clml.2018.07.208
- By:
- Publication type:
- Article
Interim Report from a Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor: Clinical Activity and Favorable Safety in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S380, doi. 10.1016/j.clml.2017.07.227
- By:
- Publication type:
- Article
Does PET Reconstruction Method Affect Deauville Score in Lymphoma Patients?
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 7, p. 1049, doi. 10.2967/jnumed.117.202721
- By:
- Publication type:
- Article
Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 1996, v. 53, n. 3, p. 175, doi. 10.1002/(SICI)1096-8652(199611)53:3<175::AID-AJH5>3.0.CO;2-W
- By:
- Publication type:
- Article
Assessment of alteration in liver <sup>18</sup>F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 6, p. 941, doi. 10.1007/s00259-017-3914-y
- By:
- Publication type:
- Article
Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 699, doi. 10.1007/s00259-017-3899-6
- By:
- Publication type:
- Article
Correction to: Diagnostic and prognostic value of baseline FDG PET/CT skeletal textural features in diffuse large B cell lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- Correction Notice